PubMed ID:
37263570
Public Release Type:
Journal
Publication Year: 2023
DOI:
https://doi.org/10.1053/j.ajkd.2023.03.010
Authors:
Menez Steven, Coca Steven G., Moledina Dennis G., Wen Yumeng, Chan Lili, Thiessen-Philbrook Heather, Obeid Wassim, Garibaldi Brian T., Azeloglu Evren U., Ugwuowo Ugochukwu, Sperati C. John, Arend Lois J., Rosenberg Avi Z., Kaushal Madhurima, Jain Sanjay, Wilson F. Perry, Parikh Chirag R., Deng Jie, Deng Jie, Atta Mo, Bagnasco Serena M., Ko Albert, Iwasaki Akiko, Farhadian Shelli, Nelson Allison, Casanovas-Massana Arnau, White Elizabeth B., Schulz Wade, Coppi Andreas, Young Patrick, Nunez Angela, Shepard Denise, Matos Irene, Strong Yvette, Anastasio Kelly, Brower Kristina, Kuang Maxine, Chiorazzi Michael, Bermejo Santos, Vijayakumar Pavithra, Geng Bertie, Fournier John, Minasyan Maksym, Muenker M. Catherine, Moore Adam J., Nadkarni Girish
Request IDs:
22361
Studies:
Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury
Patients hospitalized with COVID-19 are at increased risk for major adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE in patients hospitalized with COVID-19.